Worldwide Healthcare Trust PLC GBPLSE: WWH

Worldwide Healthcare Trust PLC GBP: Transaction in Own Shares

· Issued by Worldwide Healthcare Trust PLC GBP via PR Newswire

Summary by 6ix AI

Worldwide Healthcare Trust PLC bought 1,493,944 of its Ordinary shares of 2.5p each on the market on September 30, 2026, at a price of 381.56 pence per share. It will hold the shares in treasury, meaning the company keeps them rather than cancelling them.

Key details

  • The purchase was made under authority given at the company's Annual General Meeting on July 14, 2026, which allows it to buy back up to an aggregate maximum of 53,782,409 of its own shares.
  • After this purchase, the company holds 259,582,858 Ordinary shares in treasury and has 601,665,200 Ordinary shares in issue.
  • Total voting rights in the company after the repurchase are 342,082,342. Shareholders may use this figure to work out whether they must report their holdings under the disclosure rules of the Financial Conduct Authority, the UK financial regulator.

6ix AI wrote this summary from the release below and checked it against the release.

For immediate release

30 September 2026

WORLDWIDE HEALTHCARE TRUST PLC

(the "Company")

MARKET PURCHASE OF COMPANY'S OWN SHARES

This notification is given, pursuant to the authority granted at an Annual General Meeting of the Company held on 14 July 2026 to make market purchases of the Company's own shares up to an aggregate maximum of 53,782,409.

The Company has purchased a market total of 1,493,944 Ordinary shares of 2.5p each in the capital of the Company today at a price of 381.56 pence per share. These shares will be held in treasury.

Following this transaction, the Company hereby notifies the market that the resultant number of Ordinary shares held by the Company in treasury is 259,582,858 and the total number of Ordinary shares that the Company has in issue is 601,665,200 so that the total number of voting rights in the Company following the repurchase is 342,082,342.

The figure of 342,082,342 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For and on behalf of

Frostrow Capital LLP

Company Secretary

For further information, please contact:

Mark Pope

Frostrow Capital LLP

Tel: 020 3 0084913




Worldwide Healthcare Trust PLC GBP on 6ix

Earlier from Worldwide Healthcare Trust PLC GBP

Later from Worldwide Healthcare Trust PLC GBP

All Worldwide Healthcare Trust PLC GBP news releases